世界の陽電子放出断層撮影（PET）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Preclinical Positron Emission Tomography (PET) Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4751 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、陽電子放出断層撮影（PET）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（構造画像、機能画像）、用途別市場規模（製薬会社、委託研究機関（CRO）、バイオテクノロジー会社、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・陽電子放出断層撮影（PET）の市場動向 ・企業の競争状況、市場シェア ・陽電子放出断層撮影（PET）の種類別市場規模（構造画像、機能画像） ・陽電子放出断層撮影（PET）の用途別市場規模（製薬会社、委託研究機関（CRO）、バイオテクノロジー会社、その他） ・陽電子放出断層撮影（PET）の北米市場規模2016-2027（アメリカ、カナダ） ・陽電子放出断層撮影（PET）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・陽電子放出断層撮影（PET）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・陽電子放出断層撮影（PET）の中南米市場規模2016-2027（メキシコ、ブラジル） ・陽電子放出断層撮影（PET）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（TriFoil Imaging、Bruker Corporation、Mediso、Spectral Instruments Imaging、MR Solutions、Aspect Imaging） ・結論

PET creates three-dimensional (3D) images of a subject using radioactive tracers – molecules bound to a radioactive isotope – that are usually injected intravenously. The carrier molecule can bind to specific proteins, receptors, and biomolecular pathways in the body, to quantify a specific biological activity.

Market Analysis and Insights: Global Preclinical Positron Emission Tomography (PET) Market
The global Preclinical Positron Emission Tomography (PET) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Preclinical Positron Emission Tomography (PET) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Preclinical Positron Emission Tomography (PET) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Preclinical Positron Emission Tomography (PET) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Preclinical Positron Emission Tomography (PET) market.

Global Preclinical Positron Emission Tomography (PET) Scope and Market Size
Preclinical Positron Emission Tomography (PET) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Preclinical Positron Emission Tomography (PET) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Structural Imaging
Functional Imaging

Segment by Application
Pharmaceutical Companies
Contract Research Organization (CRO’s)
Biotech Companies
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
TriFoil Imaging
Bruker Corporation
Mediso
Spectral Instruments Imaging
MR Solutions
Aspect Imaging

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preclinical Positron Emission Tomography (PET) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Structural Imaging
1.2.3 Functional Imaging
1.3 Market by Application
1.3.1 Global Preclinical Positron Emission Tomography (PET) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical Companies
1.3.3 Contract Research Organization (CRO’s)
1.3.4 Biotech Companies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Preclinical Positron Emission Tomography (PET) Market Perspective (2016-2027)
2.2 Preclinical Positron Emission Tomography (PET) Growth Trends by Regions
2.2.1 Preclinical Positron Emission Tomography (PET) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Preclinical Positron Emission Tomography (PET) Historic Market Share by Regions (2016-2021)
2.2.3 Preclinical Positron Emission Tomography (PET) Forecasted Market Size by Regions (2022-2027)
2.3 Preclinical Positron Emission Tomography (PET) Industry Dynamic
2.3.1 Preclinical Positron Emission Tomography (PET) Market Trends
2.3.2 Preclinical Positron Emission Tomography (PET) Market Drivers
2.3.3 Preclinical Positron Emission Tomography (PET) Market Challenges
2.3.4 Preclinical Positron Emission Tomography (PET) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Preclinical Positron Emission Tomography (PET) Players by Revenue
3.1.1 Global Top Preclinical Positron Emission Tomography (PET) Players by Revenue (2016-2021)
3.1.2 Global Preclinical Positron Emission Tomography (PET) Revenue Market Share by Players (2016-2021)
3.2 Global Preclinical Positron Emission Tomography (PET) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Preclinical Positron Emission Tomography (PET) Revenue
3.4 Global Preclinical Positron Emission Tomography (PET) Market Concentration Ratio
3.4.1 Global Preclinical Positron Emission Tomography (PET) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preclinical Positron Emission Tomography (PET) Revenue in 2020
3.5 Preclinical Positron Emission Tomography (PET) Key Players Head office and Area Served
3.6 Key Players Preclinical Positron Emission Tomography (PET) Product Solution and Service
3.7 Date of Enter into Preclinical Positron Emission Tomography (PET) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Preclinical Positron Emission Tomography (PET) Breakdown Data by Type
4.1 Global Preclinical Positron Emission Tomography (PET) Historic Market Size by Type (2016-2021)
4.2 Global Preclinical Positron Emission Tomography (PET) Forecasted Market Size by Type (2022-2027)

5 Preclinical Positron Emission Tomography (PET) Breakdown Data by Application
5.1 Global Preclinical Positron Emission Tomography (PET) Historic Market Size by Application (2016-2021)
5.2 Global Preclinical Positron Emission Tomography (PET) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Preclinical Positron Emission Tomography (PET) Market Size (2016-2027)
6.2 North America Preclinical Positron Emission Tomography (PET) Market Size by Type
6.2.1 North America Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2021)
6.2.2 North America Preclinical Positron Emission Tomography (PET) Market Size by Type (2022-2027)
6.2.3 North America Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2027)
6.3 North America Preclinical Positron Emission Tomography (PET) Market Size by Application
6.3.1 North America Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2021)
6.3.2 North America Preclinical Positron Emission Tomography (PET) Market Size by Application (2022-2027)
6.3.3 North America Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2027)
6.4 North America Preclinical Positron Emission Tomography (PET) Market Size by Country
6.4.1 North America Preclinical Positron Emission Tomography (PET) Market Size by Country (2016-2021)
6.4.2 North America Preclinical Positron Emission Tomography (PET) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Preclinical Positron Emission Tomography (PET) Market Size (2016-2027)
7.2 Europe Preclinical Positron Emission Tomography (PET) Market Size by Type
7.2.1 Europe Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2021)
7.2.2 Europe Preclinical Positron Emission Tomography (PET) Market Size by Type (2022-2027)
7.2.3 Europe Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2027)
7.3 Europe Preclinical Positron Emission Tomography (PET) Market Size by Application
7.3.1 Europe Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2021)
7.3.2 Europe Preclinical Positron Emission Tomography (PET) Market Size by Application (2022-2027)
7.3.3 Europe Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2027)
7.4 Europe Preclinical Positron Emission Tomography (PET) Market Size by Country
7.4.1 Europe Preclinical Positron Emission Tomography (PET) Market Size by Country (2016-2021)
7.4.2 Europe Preclinical Positron Emission Tomography (PET) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size (2016-2027)
8.2 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Type
8.2.1 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2027)
8.3 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Application
8.3.1 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2027)
8.4 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Region
8.4.1 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Preclinical Positron Emission Tomography (PET) Market Size (2016-2027)
9.2 Latin America Preclinical Positron Emission Tomography (PET) Market Size by Type
9.2.1 Latin America Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2021)
9.2.2 Latin America Preclinical Positron Emission Tomography (PET) Market Size by Type (2022-2027)
9.2.3 Latin America Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2027)
9.3 Latin America Preclinical Positron Emission Tomography (PET) Market Size by Application
9.3.1 Latin America Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2021)
9.3.2 Latin America Preclinical Positron Emission Tomography (PET) Market Size by Application (2022-2027)
9.3.3 Latin America Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2027)
9.4 Latin America Preclinical Positron Emission Tomography (PET) Market Size by Country
9.4.1 Latin America Preclinical Positron Emission Tomography (PET) Market Size by Country (2016-2021)
9.4.2 Latin America Preclinical Positron Emission Tomography (PET) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size (2016-2027)
10.2 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Type
10.2.1 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2027)
10.3 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Application
10.3.1 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2027)
10.4 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Country
10.4.1 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 TriFoil Imaging
11.1.1 TriFoil Imaging Company Details
11.1.2 TriFoil Imaging Business Overview
11.1.3 TriFoil Imaging Preclinical Positron Emission Tomography (PET) Introduction
11.1.4 TriFoil Imaging Revenue in Preclinical Positron Emission Tomography (PET) Business (2016-2021)
11.1.5 TriFoil Imaging Recent Development
11.2 Bruker Corporation
11.2.1 Bruker Corporation Company Details
11.2.2 Bruker Corporation Business Overview
11.2.3 Bruker Corporation Preclinical Positron Emission Tomography (PET) Introduction
11.2.4 Bruker Corporation Revenue in Preclinical Positron Emission Tomography (PET) Business (2016-2021)
11.2.5 Bruker Corporation Recent Development
11.3 Mediso
11.3.1 Mediso Company Details
11.3.2 Mediso Business Overview
11.3.3 Mediso Preclinical Positron Emission Tomography (PET) Introduction
11.3.4 Mediso Revenue in Preclinical Positron Emission Tomography (PET) Business (2016-2021)
11.3.5 Mediso Recent Development
11.4 Spectral Instruments Imaging
11.4.1 Spectral Instruments Imaging Company Details
11.4.2 Spectral Instruments Imaging Business Overview
11.4.3 Spectral Instruments Imaging Preclinical Positron Emission Tomography (PET) Introduction
11.4.4 Spectral Instruments Imaging Revenue in Preclinical Positron Emission Tomography (PET) Business (2016-2021)
11.4.5 Spectral Instruments Imaging Recent Development
11.5 MR Solutions
11.5.1 MR Solutions Company Details
11.5.2 MR Solutions Business Overview
11.5.3 MR Solutions Preclinical Positron Emission Tomography (PET) Introduction
11.5.4 MR Solutions Revenue in Preclinical Positron Emission Tomography (PET) Business (2016-2021)
11.5.5 MR Solutions Recent Development
11.6 Aspect Imaging
11.6.1 Aspect Imaging Company Details
11.6.2 Aspect Imaging Business Overview
11.6.3 Aspect Imaging Preclinical Positron Emission Tomography (PET) Introduction
11.6.4 Aspect Imaging Revenue in Preclinical Positron Emission Tomography (PET) Business (2016-2021)
11.6.5 Aspect Imaging Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Preclinical Positron Emission Tomography (PET) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Structural Imaging
Table 3. Key Players of Functional Imaging
Table 4. Global Preclinical Positron Emission Tomography (PET) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Preclinical Positron Emission Tomography (PET) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Preclinical Positron Emission Tomography (PET) Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Preclinical Positron Emission Tomography (PET) Market Share by Regions (2016-2021)
Table 8. Global Preclinical Positron Emission Tomography (PET) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Preclinical Positron Emission Tomography (PET) Market Share by Regions (2022-2027)
Table 10. Preclinical Positron Emission Tomography (PET) Market Trends
Table 11. Preclinical Positron Emission Tomography (PET) Market Drivers
Table 12. Preclinical Positron Emission Tomography (PET) Market Challenges
Table 13. Preclinical Positron Emission Tomography (PET) Market Restraints
Table 14. Global Preclinical Positron Emission Tomography (PET) Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Preclinical Positron Emission Tomography (PET) Market Share by Players (2016-2021)
Table 16. Global Top Preclinical Positron Emission Tomography (PET) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preclinical Positron Emission Tomography (PET) as of 2020)
Table 17. Ranking of Global Top Preclinical Positron Emission Tomography (PET) Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Preclinical Positron Emission Tomography (PET) Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Preclinical Positron Emission Tomography (PET) Product Solution and Service
Table 21. Date of Enter into Preclinical Positron Emission Tomography (PET) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Preclinical Positron Emission Tomography (PET) Revenue Market Share by Type (2016-2021)
Table 25. Global Preclinical Positron Emission Tomography (PET) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Preclinical Positron Emission Tomography (PET) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Preclinical Positron Emission Tomography (PET) Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Preclinical Positron Emission Tomography (PET) Revenue Market Share by Application (2016-2021)
Table 29. Global Preclinical Positron Emission Tomography (PET) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Preclinical Positron Emission Tomography (PET) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Preclinical Positron Emission Tomography (PET) Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Preclinical Positron Emission Tomography (PET) Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Preclinical Positron Emission Tomography (PET) Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Preclinical Positron Emission Tomography (PET) Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Preclinical Positron Emission Tomography (PET) Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Preclinical Positron Emission Tomography (PET) Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Preclinical Positron Emission Tomography (PET) Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Preclinical Positron Emission Tomography (PET) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Preclinical Positron Emission Tomography (PET) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Preclinical Positron Emission Tomography (PET) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Preclinical Positron Emission Tomography (PET) Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Preclinical Positron Emission Tomography (PET) Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Country (2022-2027) & (US$ Million)
Table 61. TriFoil Imaging Company Details
Table 62. TriFoil Imaging Business Overview
Table 63. TriFoil Imaging Preclinical Positron Emission Tomography (PET) Product
Table 64. TriFoil Imaging Revenue in Preclinical Positron Emission Tomography (PET) Business (2016-2021) & (US$ Million)
Table 65. TriFoil Imaging Recent Development
Table 66. Bruker Corporation Company Details
Table 67. Bruker Corporation Business Overview
Table 68. Bruker Corporation Preclinical Positron Emission Tomography (PET) Product
Table 69. Bruker Corporation Revenue in Preclinical Positron Emission Tomography (PET) Business (2016-2021) & (US$ Million)
Table 70. Bruker Corporation Recent Development
Table 71. Mediso Company Details
Table 72. Mediso Business Overview
Table 73. Mediso Preclinical Positron Emission Tomography (PET) Product
Table 74. Mediso Revenue in Preclinical Positron Emission Tomography (PET) Business (2016-2021) & (US$ Million)
Table 75. Mediso Recent Development
Table 76. Spectral Instruments Imaging Company Details
Table 77. Spectral Instruments Imaging Business Overview
Table 78. Spectral Instruments Imaging Preclinical Positron Emission Tomography (PET) Product
Table 79. Spectral Instruments Imaging Revenue in Preclinical Positron Emission Tomography (PET) Business (2016-2021) & (US$ Million)
Table 80. Spectral Instruments Imaging Recent Development
Table 81. MR Solutions Company Details
Table 82. MR Solutions Business Overview
Table 83. MR Solutions Preclinical Positron Emission Tomography (PET) Product
Table 84. MR Solutions Revenue in Preclinical Positron Emission Tomography (PET) Business (2016-2021) & (US$ Million)
Table 85. MR Solutions Recent Development
Table 86. Aspect Imaging Company Details
Table 87. Aspect Imaging Business Overview
Table 88. Aspect Imaging Preclinical Positron Emission Tomography (PET) Product
Table 89. Aspect Imaging Revenue in Preclinical Positron Emission Tomography (PET) Business (2016-2021) & (US$ Million)
Table 90. Aspect Imaging Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Preclinical Positron Emission Tomography (PET) Market Share by Type: 2020 VS 2027
Figure 2. Structural Imaging Features
Figure 3. Functional Imaging Features
Figure 4. Global Preclinical Positron Emission Tomography (PET) Market Share by Application: 2020 VS 2027
Figure 5. Pharmaceutical Companies Case Studies
Figure 6. Contract Research Organization (CRO’s) Case Studies
Figure 7. Biotech Companies Case Studies
Figure 8. Others Case Studies
Figure 9. Preclinical Positron Emission Tomography (PET) Report Years Considered
Figure 10. Global Preclinical Positron Emission Tomography (PET) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Preclinical Positron Emission Tomography (PET) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Preclinical Positron Emission Tomography (PET) Market Share by Regions: 2020 VS 2027
Figure 13. Global Preclinical Positron Emission Tomography (PET) Market Share by Regions (2022-2027)
Figure 14. Global Preclinical Positron Emission Tomography (PET) Market Share by Players in 2020
Figure 15. Global Top Preclinical Positron Emission Tomography (PET) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preclinical Positron Emission Tomography (PET) as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Preclinical Positron Emission Tomography (PET) Revenue in 2020
Figure 17. Global Preclinical Positron Emission Tomography (PET) Revenue Market Share by Type (2016-2021)
Figure 18. Global Preclinical Positron Emission Tomography (PET) Revenue Market Share by Type (2022-2027)
Figure 19. North America Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Preclinical Positron Emission Tomography (PET) Market Share by Type (2016-2027)
Figure 21. North America Preclinical Positron Emission Tomography (PET) Market Share by Application (2016-2027)
Figure 22. North America Preclinical Positron Emission Tomography (PET) Market Share by Country (2016-2027)
Figure 23. United States Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Preclinical Positron Emission Tomography (PET) Market Share by Type (2016-2027)
Figure 27. Europe Preclinical Positron Emission Tomography (PET) Market Share by Application (2016-2027)
Figure 28. Europe Preclinical Positron Emission Tomography (PET) Market Share by Country (2016-2027)
Figure 29. Germany Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Share by Region (2016-2027)
Figure 39. China Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Preclinical Positron Emission Tomography (PET) Market Share by Type (2016-2027)
Figure 47. Latin America Preclinical Positron Emission Tomography (PET) Market Share by Application (2016-2027)
Figure 48. Latin America Preclinical Positron Emission Tomography (PET) Market Share by Country (2016-2027)
Figure 49. Mexico Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Share by Country (2016-2027)
Figure 55. Turkey Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. TriFoil Imaging Revenue Growth Rate in Preclinical Positron Emission Tomography (PET) Business (2016-2021)
Figure 59. Bruker Corporation Revenue Growth Rate in Preclinical Positron Emission Tomography (PET) Business (2016-2021)
Figure 60. Mediso Revenue Growth Rate in Preclinical Positron Emission Tomography (PET) Business (2016-2021)
Figure 61. Spectral Instruments Imaging Revenue Growth Rate in Preclinical Positron Emission Tomography (PET) Business (2016-2021)
Figure 62. MR Solutions Revenue Growth Rate in Preclinical Positron Emission Tomography (PET) Business (2016-2021)
Figure 63. Aspect Imaging Revenue Growth Rate in Preclinical Positron Emission Tomography (PET) Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---